GOOD PRACTICES Approach to Aging in HIV Care Discussing the effects of aging with patients who have HIV and are ≥50 years old can help identify medical priorities and evaluate physical function. Such conversations may also prompt consideration of advance directives and help patients recognize the effects of age-associated stigma. Taking a proactive approach to … Continue reading “Approach to Aging in HIV Care”
Essential components of an HIV-specific medical history are detailed below and in Table 1: HIV, Medications, and General Medical Status and History for Adults With HIV. Confirmation of a patient’s HIV infection should include documented laboratory testing results. If results are not available, baseline testing should be performed as noted in Table 1 (also see … Continue reading “HIV-Specific Medical History”
Patients with HIV receive care in diverse settings [Cheng, et al. 2014]. A patient may receive primary care from an HIV or infectious diseases specialist with a strong, disease-specific focus or may seek HIV care from a primary care provider who does not specialize in HIV care. Some studies have suggested better outcomes when patients … Continue reading “Goals of Primary Care for Adults With HIV”
RECOMMENDATION Treatment of lesions solely for the prevention of future transmission cannot be recommended because the value of treatment in reducing infectivity is not known. However, sex partners of patients who have genital lesions might benefit from counseling and examination to assess the presence of genital warts and HPV-related dysplasia. Sex partners should also be … Continue reading “Partner Exposure to HIV and HPV”
Mental health: Mental health disorders are not contraindications to treatment of chronic hepatitis C virus (HCV) infection with direct-acting antivirals (DAAs). Strategies to overcome mental health-related barriers to successful HCV treatment include counseling, education, and referral to psychiatry and behavioral health services. Patients with mental health disorders may need increased attention to management of adverse … Continue reading “Mental Health, Substance Use, and Adherence”
The Perinatal Transmission Guideline Prevention Committee recommends that clinicians follow the DHHS guideline Management of Infants Born to Women with HIV Infection in addition to these good practices specific to New York State.
Go to the NYS Good Practices | Download the PDF
RECOMMENDATIONS ——— Notes: Clinical Education Initiative (CEI) Line for expert consultation: Clinicians in New York State can speak with an experienced HIV care provider 24/7 regarding maternal or fetal HIV exposure by calling the CEI Line: 1-866-637-2342, option 2. See U.S. Department of Health and Human Services Recommendations for the Use of Antiretroviral Drugs in … Continue reading “HIV Testing During Labor and in Newborns”
RECOMMENDATIONS ——— Abbreviations: Ab, antibody; Ag, antigen; ART, antiretroviral therapy; CEI, Clinical Education Initiative; FDA, U.S. Food and Drug Administration; PEP, post-exposure prophylaxis; PrEP, pre-exposure prophylaxis; STI, sexually transmitted infection; TDF/FTC, tenofovir disoproxil fumarate/emtricitabine. Note: CEI Line for expert consultation: Clinicians in New York State can speak with an experienced HIV care provider 24/7 regarding … Continue reading “Universal HIV Screening in Pregnancy”
RECOMMENDATIONS ——— Abbreviations: Ab, antibody; Ag, antigen; FDA, U.S. Food and Drug Administration. Before the HIV-1/2 Ag/Ab combination and HIV-1/HIV-2 Ab differentiation immunoassays for HIV testing became widely available, clinicians suspected chronic HIV-2 infection in certain clinical scenarios, such as a declining CD4 count in an HIV-1-seropositive, untreated individual with an undetectable HIV-1 plasma viral … Continue reading “Diagnosis of HIV-2”
RECOMMENDATIONS ——— Abbreviations: Ag/Ab, antigen/antibody; APHL, Association of Public Health Laboratories; ART, antiretroviral therapy; CAB LA, long-acting injectable cabotegravir (brand name Apretude); CDC, Centers for Disease Control and Prevention; CEI, Clinical Education Initiative; DRV/COBI, cobicistat-boosted darunavir (brand name Prezcobix); DTG, dolutegravir (brand name Tivicay); BIC, bictegravir; INSTI, integrase strand transfer inhibitor; PrEP, pre-exposure prophylaxis; TAF/FTC, … Continue reading “Managing a Positive HIV Test Result”